August 01, 2014 4:51 AM ET

Healthcare Equipment and Supplies

Company Overview of CooperVision, Inc.

Company Overview

CooperVision, Inc. engages in the manufacture and distribution of contact lenses. The company specializes in lenses for astigmatism, presbyopia, and ocular dryness serving practitioners and patients. It offers contact lens materials and optics, including naturally wettable silicone hydrogel lenses; spherical, toric, and multifocal products; and monthly, two-week, and daily disposable contact lenses. CooperVision, Inc. was formerly known as Cooper Laboratories and changed its name to CooperVision, Inc. in January 1979. The company was founded in 1958 and is based in Fairport, New York with an additional office in Pleasanton, California. CooperVision, Inc. operates as a subsidiary of The Coope...

370 Woodcliff Drive

Suite 200

Fairport, NY 14450

United States

Founded in 1958

Phone:

716-385-6810

Fax:

716-889-5688

Key Executives for CooperVision, Inc.

President and Chief Operating Officer
Age: 50
Chief Executive Officer of Cooper Companies
Age: 67
Executive Vice President of Global Commercial Strategy and President of Americas
Age: 60
President of Coopervision US
President of Europe
Compensation as of Fiscal Year 2014.

CooperVision, Inc. Key Developments

CooperVision Reports Revenue Results for the First Quarter Ended January 31, 2014; Revises Revenue Guidance for the Fiscal Year 2014

CooperVision reported revenue results for the first quarter ended January 31, 2014. For the quarter, the company reported revenue up 8% to $326.3 million, up 14% in constant currency and excluding the divestiture of Aime. For the fiscal year 2014, the company expected revenues to be in the range of $1,365 million to $1,395 million compared to previously expected revenues of $1,355 million to $1,395 million.

CooperVision, Inc. Announces Executive Changes

CooperVision, Inc. announced that John Weber will resign as President and transition to Executive Vice President of the company effective February 1, 2014. On February 1, 2014, Daniel McBride, Chief Operating Officer of The Cooper Companies, Inc. will assume the additional role of President of the company.

CooperVision Launches Biofinity(R) XR Contact Lenses

CooperVision Inc. announced the launch of its Biofinity(R) XR contact lens brand. This is an extension to its popular Biofinity (comfilcon A) silicone hydrogel technology, allowing practitioners to confidently fit a greater number of monthly replacement lens patients, including those with significant hyperopia and myopia. The Biofinity XR lens is the first of its kind that combines high oxygen permeability with all-day comfort characteristics required for wearers with more demanding prescriptions. With Biofinity XR, more people can enjoy the benefits of modern contact lens material and design, helping them live life without the hassle of glasses. Biofinity XR lenses are now available in powers from +8.50 to +15.00 (0.50 steps) and -12.50 to -20.00 (0.50 steps). The current Biofinity line continues to be available in +8.00 to -12.00 powers.

Similar Private Companies By Industry

Company Name Region
LumiThera, Inc. United States
Focal Therapeutics United States
Hi-tronics Designs, Inc. United States
Futuro, Inc. United States
Certified Safety Manufacturing, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CooperVision, Inc., please visit www.coopervision.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.